✦ LIBER ✦

7134 POSTER Updated Safety and Efficacy Results for Sunitinib From a Global, Expanded-Access Trial in Metastatic Renal Cell Carcinoma (mRCC)

✍ Scribed by Gore, M.; Porta, C.; Bracarda, S.; Crinö, L.; Hawkins, R.; Bjarnason, G.; Oudard, S.; Lee, S.H.; Kim, T.M.; Szczylik, C.

Book ID: 123490964
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 43 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)72049-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SAFETY AND EFFICACY OF SUNITINIB IN AN E

SAFETY AND EFFICACY OF SUNITINIB IN AN EXPANDED-ACCESS TRIAL OF METASTATIC RENAL CELL CARCINOMA (MRCC): UPDATED RESULTS AND SUBPOPULATION ANALYSIS

✍ S. Oudard; C. Szczylik; C. Porta; S. Bracarda; R. Hawkins; G. Bjarnason; S.H. Le 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Safety and efficacy of sunitinib for met

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

✍ Martin E Gore; Cezary Szczylik; Camillo Porta; Sergio Bracarda; Georg A Bjarnaso 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 143 KB

4503 ORAL Sunitinib in metastatic renal

4503 ORAL Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of safety and efficacy in an expanded access trial with subpopulation analysis

✍ Gore, M.; Szczylik, C.; Porta, C.; Bracarda, S.; Hawkins, R.; Bjarnason, G.; Oud 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

4510 POSTER A phase 2 trial of sunitinib

4510 POSTER A phase 2 trial of sunitinib in bevacizumab-refractory metastatic renal cell carcinoma (mRCC): updated results and analysis of circulating biomarkers

✍ Hutson, T.E.; George, D.J.; Michaelson, M.D.; Rosenberg, J.E.; Bukowski, R.M.; S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 65 KB

SAFETY AND EFFICACY OF SUNITINIB IN META

SAFETY AND EFFICACY OF SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (mRCC): PRELIMINARY ASSESSMENT OF AN ITALIAN EXPANDED-ACCESS PROGRAM (EAP) WITH SUBPOPULATION ANALYSIS

✍ Sternberg, Cora N; Porta, Camillo; Bracarda, Sergio; Carteni, Giacomo; Re, Giova 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 191 KB

SUNITINIB AS FIRST-LINE TREATMENT FOR ME

SUNITINIB AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA (MRCC): UPDATED RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS FROM A PHASE III RANDOMISED TRIAL

✍ S. Oudard; R.J. Motzer; M.D. Michaelson; T.E. Hutson; P. Tomczak; R.M. Bukowski; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB